Satellos Bioscience share price logo

Satellos Bioscience

NASDAQ: MSLE

$7.41

+0.29

(+4.07%)

Live

as on

Satellos Bioscience Stock Performance

as on November 10, 2026 at 6:35 am IST

  • Day's Low

    $7.02
    $7.41
    downward going graph

    5.26%

    Downside

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Satellos Bioscience share price movements today

Previous Close
$7.12
Open
$7.24
Volume
223.2K
Market Cap
$152.5M
Day's Low - High
$7.02 - $7.41

Satellos Bioscience Historical Returns

1 Month Return
-4.94 %
3 Month Return
-29.01 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Satellos Bioscience Stock Fundamentals & Key Indicators

Check Satellos Bioscience market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$152.5M

EPS (TTM)

-2.1448

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.62

Industry PE ratio

-3.15

PEG Ratio

-0.72

EBITDA

-35.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-72.67%

Satellos Bioscience vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Satellos Bioscience with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Satellos Bioscience image
Satellos Bioscience
Buy$152.5MNA-3.620.00%0.00%
Moderna image
Moderna
Neutral$101.5B7.32%-35.9528.00%0.00%
BeOne Medicines image
BeOne Medicines
StrongBuy$46.5BNA66.6588.39%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$138.7B186.30%34.9485.57%0.00%
Regeneron image
Regeneron
Buy$93.5B46.74%19.2685.77%0.41%

Analyst Recommendation on Satellos Bioscience Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Satellos Bioscience. Average target price of $19

Satellos Bioscience Share Price Target

Get share price movements and forecasts by analysts on Satellos Bioscience.

Current Price

$7.41

Analyzed by

2 Analysts

High

$20

0

Low

$18

Satellos Bioscience target price $0, a slight upside of 0% compared to current price of $7.41. According to 2 analysts rating.

Indian Investors' Interest in Satellos Bioscience Stock

Search interest for Satellos Bioscience Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-21% versus previous 30 day period

Satellos Bioscience Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-5
0
0
-
0
0
0
0
-7
0
Operating Income
-8
-6
-5
-7
-6
-6
-5
-7
-10
-12
EBITDA
-6
-6
-9
-6
-6
-
-5
-7
-10
-12
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
-
0
0
0
0
Income Before Tax
-6
-6
-9
-6
-6
-5
-5
-7
-9
-11
Income Tax Expense
-
-
-
-
0
0
0
0
0
0
Net Income
-6
-6
-9
-6
-6
-5
-5
-7
-9
-12
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Satellos Bioscience Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
-3
-8
0
0
Operating Income
-2
-2
-2
-6
-8
-15
-27
-26
EBITDA
-2
-1
-1
-4
-8
-15
-28
-26
Interest Expense
-
-
0
0
-
0
-
-
Depreciation
-
0
0
0
0
0
0
0
Income Before Tax
-1
-2
-1
-15
-11
-15
-28
-25
Income Tax Expense
-
0
0
0
0
-
-
0
Net Income
-1
-1
-1
-15
-11
-15
-28
-25
Net Profit Margin
0.00%
-5030.14%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Satellos Bioscience Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-6
-6
-9
-6
-6
-5
-5
-7
-9
-11
Operating Cash Flow
-7
-5
-4
-7
-7
-4
-4
-7
-9
-7
Investing Cash Flow
-2
2
17
-11
-
8
-15
-2
-32
-3
Financing Cash Flow
-
0
0
53
0
1
0
0
51
0
Change in Cash
-8
-3
13
34
-7
5
-18
-9
9
-10

Satellos Bioscience Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-1
-1
-15
-11
-15
-28
-25
Operating Cash Flow
-1
-1
-1
-5
-5
-14
-24
-24
Investing Cash Flow
0
0
-
1
0
-17
6
-9
Financing Cash Flow
-
1
1
7
2
51
53
2
Change in Cash
-1
0
0
4
-2
20
35
-32

Global Institutional Holdings in Satellos Bioscience

Check out the Institutions with significant holdings in Satellos Bioscience.

Funds
Holdings
Franklin Milan Berger
6.49%
Michael Rockefeller
2.36%
Franklin Strategic Series
1.62%
Mark Henry Nawacki
0.19%
Fidelity Concord Street Trust
0.06%

Satellos Bioscience News & Key Events

  • img

    Today's Timeline - 06 November

    Fri, 05:36 PM

    -

    Satellos changes primary endpoint in BASECAMP trial to MRI-measured fat fraction after FDA feedback.

Insights on Satellos Bioscience

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MSLE stock has moved up by 11.3%

About Satellos Bioscience

Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
OrganisationSatellos Bioscience
HeadquartersRoyal Bank Plaza, Toronto, ON, M5J 2J1, CA
IndustryBiotechnology
CEOFrancis Gleeson

Key Management of Satellos Bioscience

Name

Title

Dr. Philip Lambert M.A., Ph.D.

Chief Scientific Officer

Dr. Wildon Farwell M.D., M.P.H.

Chief Medical Officer

Mr. Michael Liggett B.Sc., Bsc. Pharm., C.A., C.P.A.

Strategic Advisor

Ms. Desiree Chan

Chief of Staff

Dr. Ryan Mitchell Ph.D.

Senior VP & Head of Corporate Development

Mr. Warren Whitehead C.M.A., CPA

Head of Corporate Strategy

Mr. Francis Gleeson B.B.A. M.B.A

Co-Founder, CEO, President & Director

Ms. Elizabeth Williams C.A., CPA

CFO & Corporate Secretary

Dr. Michael A. Rudnicki Ph.D.

Co-Founder & Chief Discovery Officer

Mr. J. Robert Hall CFA

Senior Vice President of Finance & Administration

FAQs

What is Satellos Bioscience share price today?

Satellos Bioscience share price today is $7.41 as on . Satellos Bioscience share today touched a day high of $7.41 and a low of $7.02.

What is the 52 week high and 52 week low for Satellos Bioscience share?

Satellos Bioscience share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Satellos Bioscience stock price today i.e. is trending at $7.41,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Satellos Bioscience's market capitalisation today?

Satellos Bioscience market capitalisation is $0.00T as on .

How to invest in Satellos Bioscience Stock (MSLE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Satellos Bioscience on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Satellos Bioscience Stock (MSLE) from India?

Indian investors can start investing in Satellos Bioscience (MSLE) shares with as little as ₹93.92749786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.27 in Satellos Bioscience stock (as per the Rupee-Dollar exchange rate as on ). Based on Satellos Bioscience share’s latest price of $7.41 as on November 10, 2026 at 1:05 am IST, you will get 1.3495 shares of Satellos Bioscience. Learn more about fractional shares .